Identification of genes whose expression is altered during mitosuppression in livers of ethinyl estradiol-treated female rats

Carcinogenesis

Volumn 17, Issue 12, 1996, Pages 2783-2786

  Chen, Jinqiang ^a   Schwartz, David A ^b   Young, Thayer A ^a   Norris, James S ^b   Yager, James D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ETHINYLESTRADIOL; MESSENGER RNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE EXPRESSION; LIVER; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS;

ANIMALS; ETHINYL ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; LIVER; RATS; RATS, INBRED F344; RECEPTOR, IGF TYPE 2; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030450128     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.12.2783     Document Type: Article

References (26)

1. Yager,J.D., Roebuck,B.D., Paluszcyk,T.L. and Menoli,V.A. (1986) Effects of ethinyl estradiol and tamoxifen in liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis, 7, 2007-2014.
2. Mayol,X., Perez-Tomas,P., Cullere,X., Romero,A., Estadella,M.D. and Domingo,J. (1991) Cell proliferation and tumor promotion by ethinyl estradiol in rat hepatocarcinogenesis. Carcinogenesis, 12, 1133-1136.
3. Schulte-Herman,R. (1985) Tumor promotion in the liver. Arch. Toxicol., 57, 147-158.
4. Peraino,C., Fry,R.J.M., Staffeldt,E. and Christopher,J.P. (1975) Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res., 35, 2884-2890.
5. Tanaka,K., Smith,P.F., Stromberg,P.C., Eydelloth,R.S., Herold,E.G., Grossman,S.J., Frank,J.D., Hertzog,P.R., Soper,K.A. and Keenan,K.P. (1992) Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicol. Appl. Pharmacol., 116, 71-77.
6. Barbason,H., Rassenfosse,C. and Betz,E.H. (1983) Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect. Br. J. Cancer, 47, 517-525.
7. Yager,J.D., Zurlo,J., Sewall,H.C., Lucier,G.W. and He,H. (1994) Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. Carcinogenesis, 15, 2117-2123.
8. Jirtle,R.L. and Meyer,S.A. (1991) Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-beta expression. Digest. Dis. Sci., 36, 659-668.
9. Jirtle,R.L., Hankins,G.R., Reisenbichler,H. and Boyer,I.J. (1994) Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis, 15, 1473-1478.
10. Dennis,P.A. and Rifkin,D.B. (1991) Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin like growth factor type II receptor. Proc. Natl Acad. Sci. USA. 88, 580-584.
11. Chomczynski,P. and Sacchi,N. (1987) A single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
12. Rumshy,P.C., Davies,M.J., Price,R.J. and Lake,B.G. (1994) Effect of some peroxisome proliterators on transforming growth factor-b1 gene expression and insulin-like growth factor II/mannose 6-phosphate receptor gene expression in rat liver. Carcinogenesis, 15, 419-421.
13. Grana,X. and Reddy,E.P. (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11, 211-219.
14. Koff,A., Ohtsuki,M., Polyak,K., Roberts,J.M. and Massague,J. (1993) Negative regulation of GI in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science, 260, 536-539.
15. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitotic signals. Cell, 78, 59-66.
16. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature. 371, 257-261.
17. INK4b genes. Oncogene, 11, 635-645.
18. Liang,P. and Pardee,A.B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 961-971.
19. Liang,P., Averboukh,L. and Pardee,A.B. (1993) Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res., 21, 3269-3275.
20. Bauer,D., Muller,H., Reich,J., Riedel,H., Ahrenkiel,V., Warrhoe,P. and Strauss,M. (1993) Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res., 21, 4272-4280.
21. Altschul,S.F., Warren,G., Webb,M, Eugene,W.M. and David,J.L. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
22. Kar,S. and Carr,B.I. (1995) Differential display and cloning of messenger RNAs from the late phase of rat liver regeneration. Biochem. Biophys. Res. Commun., 212, 21-26.
23. Ogawa,T., Higashi,S., Kawarada,Y. and Mizumoto,R. (1995) Role of reactive oxygen in synthetic estrogen induction of hepatocellular carcinomas in rats and preventive effect of vitamins. Carcinogenesis, 16, 831-836.
24. Goeptar,A.R., Scheerens,H. and Vermeulen,N.P.E. (1995) Oxygen and xenobiotic reductase activities of cytochrome P450. CRC Crit. Rev. Toxicol., 25, 25-65.
25. Yager,J.D. and Liehr,J.G. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 36, 203-232.
26. El-Deiry,W.S., Tokino,T., Velculescu,V.E., Levy,D.B., Parsons,R., Trent,J.M., Lin,D., Mercer,W.E., Kinzler,K.W. and Vogelstein,B. (1993) WAF1, a potential mediator of p54 tumor suppression. Cell, 75, 817-820.